Gilead Sciences signs five-year DevOps agreement with Cognizant
The arrangement will see Cognizant combine its life sciences knowledge with technical services to aid Gilead's processes.
Drug Development
Pacira partners with Molteni for Exparel commercialisation
AstraZeneca opens new R&D centre in Cambridge, US
FDA approves expanded indication for Lilly’s Jaypirca
Bayer plans $2.2bn pharmaceutical manufacturing facility in Ohio, US
Bristol Myers Squibb secures expanded US approval for Camzyos
BioMarin and Profluent partner on AI-designed enzyme therapies
OBIO marks $704m funding milestone for Canadian health tech ventures
